Berberine Protects Against Dihydrotestosterone-Induced Human Ovarian Granulosa Cell Injury and Ferroptosis by Regulating the Circ_0097636/MiR-186-5p/SIRT3 Pathway-Reference-Cited by-同舟云学术

Berberine Protects Against Dihydrotestosterone-Induced Human Ovarian Granulosa Cell Injury and Ferroptosis by Regulating the Circ_0097636/MiR-186-5p/SIRT3 Pathway

Published:2023-12-28 Issue: Volume: Page:
ISSN:0273-2289
Container-title:Applied Biochemistry and Biotechnology
language:en
Short-container-title:Appl Biochem Biotechnol

Author:

Wang Suqin,Wang Yingfang,Qin Qin,Li Jianfang,Chen Qiaoyun,Zhang Ye,Li Xiuqing,Liu Jianrong

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s12010-023-04825-y.pdf

Reference36 articles.

1. Ganie, M. A., Vasudevan, V., Wani, I. A., Baba, M. S., Arif, T., & Rashid, A. (2019). Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. The Indian Journal of Medical Research, 150(4), 333–344.

2. Aversa, A., La Vignera, S., Rago, R., Gambineri, A., Nappi, R. E., Calogero, A. E., & Ferlin, A. (2020). Fundamental concepts and novel aspects of polycystic ovarian syndrome: Expert consensus resolutions. Frontiers in Endocrinology, 11, 516.

3. Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015). Complications and challenges associated with polycystic ovary syndrome: Current perspectives. International Journal of Women's Health, 7, 745–763.

4. Wang, J., Wu, D., Guo, H., & Li, M. (2019). Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sciences, 236, 116940.

5. Ionescu, O. M., Frincu, F., Mehedintu, A., Plotogea, M., Cirstoiu, M., Petca, A., Varlas, V., & Mehedintu, C. (2023). Berberine-A promising therapeutic approach to polycystic ovary syndrome in infertile/pregnant women. Life, 13(1), 125.